Literature DB >> 10937909

Hemangiopericytoma of the head and neck.

K R Billings1, Y S Fu, T C Calcaterra, J A Sercarz.   

Abstract

PURPOSE: To report a series of patients with hemangiopericytoma (HP) of the head and neck, to review pathological features of these tumors, and to discuss management options.
MATERIALS AND METHODS: A retrospective review of the medical records at the University of California, Los Angeles (UCLA) Medical Center in Los Angeles, CA, was done in order to identify those patients with primary HP of the head and neck, including soft tissue and mucosal sites.
RESULTS: Ten patients with HP of the head and neck were identified. There was an equal sex distribution and an average age of 36 (range 10-65). Seven of the tumors arose from soft tissue sites in the head and neck, and the remaining 3 arose from the mucosa. All patients underwent wide excision of the primary lesion with a local recurrence rate of 40%. Thirty percent of patients developed metastatic lung disease 0 to 8 years after initial diagnosis. Each patient who developed metastatic disease had abundant mitoses on pathological review compared with rare or absent mitoses in the lesions that took a more benign course.
CONCLUSIONS: Pathological appearance of resected HP is predictive of later metastatic potential. Long-term follow-up is necessary in patients even after radical resection because recurrence or metastasis may be delayed by many years.

Entities:  

Mesh:

Year:  2000        PMID: 10937909     DOI: 10.1053/ajot.2000.8378

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  17 in total

1.  Combined therapy against recurrent and intracranial invasion of sinonasal hemangiopericytoma: A case report.

Authors:  Xiaohong Wang; Jiangong Wang; Wanning Hu; Lei Wang; Yufeng Li
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

2.  [Hemangiopericytoma of the buccal mucosa. A case report].

Authors:  A Borgmann; K Becker; F Hölzle; T Mücke
Journal:  HNO       Date:  2012-03       Impact factor: 1.284

3.  Hemangiopericytoma of the neck.

Authors:  Paraskevi Tsirevelou; Paschalis Chlopsidis; Ifigenia Zourou; Dimitrios Valagiannis; Charalampos Skoulakis
Journal:  Head Face Med       Date:  2010-09-24       Impact factor: 2.151

4.  Parapharyngeal space hemangiopericytoma treated with surgery and postoperative radiation--a case report.

Authors:  Muhammad Mohsin Fareed; Abdullah Suleiman Mazaed Al Amro; Rashad Akasha; Mansour Al Assiry; Mushabbab Al Asiri; Mutahir Tonio; Yasser Bayoumi
Journal:  Head Neck Oncol       Date:  2012-04-05

5.  [Hemangiopericytoma (extrapleural solitary fibrous tumour). Exemplified and discussed on the basis of two cases].

Authors:  F Wilde; M Neid; T Schulz; I Sterker; A Hemprich; B Frerich
Journal:  Mund Kiefer Gesichtschir       Date:  2005-11

6.  Liver recurrence of a subcutaneous temporal hemangiopericytoma: the index case.

Authors:  Stéphane Zalinski; Claire Goumard; Olivier Scatton; Benoit Terris; Francoise Plantier; Nicolas Dupin; Olivier Soubrane
Journal:  J Gastrointest Surg       Date:  2009-01-16       Impact factor: 3.452

Review 7.  Update on Select Benign Mesenchymal and Meningothelial Sinonasal Tract Lesions.

Authors:  Lester D R Thompson; Julie C Fanburg-Smith
Journal:  Head Neck Pathol       Date:  2016-02-01

Review 8.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

Review 9.  Primary haemangiopericytoma of the parapharyngeal space: an unusual tumour and review of the literature.

Authors:  E N Fountoulakis; E Papadaki; I Panagiotaki; E Giannikaki; G Lagoudianakis; J Bizakis
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-03-16       Impact factor: 2.124

10.  Hemangiopericytoma of neck extending to craniovertebral junction treated by surgery, pre- and postoperative radiotherapy.

Authors:  Sudhansu Sekhar Mishra; Souvagya Panigrahi; Srikant Das; Satyabhusan Senapati
Journal:  Surg Neurol Int       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.